Literature DB >> 20798282

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Jacqueline Burré1, Manu Sharma, Theodoros Tsetsenis, Vladimir Buchman, Mark R Etherton, Thomas C Südhof.   

Abstract

Presynaptic nerve terminals release neurotransmitters repeatedly, often at high frequency, and in relative isolation from neuronal cell bodies. Repeated release requires cycles of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-complex assembly and disassembly, with continuous generation of reactive SNARE-protein intermediates. Although many forms of neurodegeneration initiate presynaptically, only few pathogenic mechanisms are known, and the functions of presynaptic proteins linked to neurodegeneration, such as α-synuclein, remain unclear. Here, we show that maintenance of continuous presynaptic SNARE-complex assembly required a nonclassical chaperone activity mediated by synucleins. Specifically, α-synuclein directly bound to the SNARE-protein synaptobrevin-2/vesicle-associated membrane protein 2 (VAMP2) and promoted SNARE-complex assembly. Moreover, triple-knockout mice lacking synucleins developed age-dependent neurological impairments, exhibited decreased SNARE-complex assembly, and died prematurely. Thus, synucleins may function to sustain normal SNARE-complex assembly in a presynaptic terminal during aging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798282      PMCID: PMC3235365          DOI: 10.1126/science.1195227

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.

Authors:  P J Kahle; M Neumann; L Ozmen; V Müller; S Odoy; N Okamoto; H Jacobsen; T Iwatsubo; J Q Trojanowski; H Takahashi; K Wakabayashi; N Bogdanovic; P Riederer; H A Kretzschmar; C Haass
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

2.  Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.

Authors:  Sreeganga Chandra; Francesco Fornai; Hyung-Bae Kwon; Umar Yazdani; Deniz Atasoy; Xinran Liu; Robert E Hammer; Giuseppe Battaglia; Dwight C German; Pablo E Castillo; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

3.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

4.  A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.

Authors:  Chang-Wei Liu; Benoit I Giasson; Karen A Lewis; Virginia M Lee; George N Demartino; Philip J Thomas
Journal:  J Biol Chem       Date:  2005-04-19       Impact factor: 5.157

5.  A broken alpha -helix in folded alpha -Synuclein.

Authors:  Sreeganga Chandra; Xiaocheng Chen; Josep Rizo; Reinhard Jahn; Thomas C Südhof
Journal:  J Biol Chem       Date:  2003-02-13       Impact factor: 5.157

6.  Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.

Authors:  Venu M Nemani; Wei Lu; Victoria Berge; Ken Nakamura; Bibiana Onoa; Michael K Lee; Farrukh A Chaudhry; Roger A Nicoll; Robert H Edwards
Journal:  Neuron       Date:  2010-01-14       Impact factor: 17.173

7.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.

Authors:  Sreeganga Chandra; Gilbert Gallardo; Rafael Fernández-Chacón; Oliver M Schlüter; Thomas C Südhof
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

8.  Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment.

Authors:  S W Scheff; D A Price; F A Schmitt; S T DeKosky; E J Mufson
Journal:  Neurology       Date:  2007-05-01       Impact factor: 9.910

9.  Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology.

Authors:  Bryony C Gray; Zuzana Siskova; V Hugh Perry; Vincent O'Connor
Journal:  Neurobiol Dis       Date:  2009-04-10       Impact factor: 5.996

Review 10.  Membrane fusion.

Authors:  William Wickner; Randy Schekman
Journal:  Nat Struct Mol Biol       Date:  2008-07       Impact factor: 15.369

View more
  726 in total

Review 1.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

2.  Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation.

Authors:  Jonathan A Fauerbach; Dmytro A Yushchenko; Sarah H Shahmoradian; Wah Chiu; Thomas M Jovin; Elizabeth A Jares-Erijman
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

Review 3.  A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders.

Authors:  Paige M Dexter; Kim A Caldwell; Guy A Caldwell
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  CSPα knockout causes neurodegeneration by impairing SNAP-25 function.

Authors:  Manu Sharma; Jacqueline Burré; Peter Bronk; Yingsha Zhang; Wei Xu; Thomas C Südhof
Journal:  EMBO J       Date:  2011-12-20       Impact factor: 11.598

5.  Impaired spatial and working memory in ageing mice with targeted inactivation of α-synuclein gene.

Authors:  V S Kokhan; G I Van'kin; N N Ninkina; T A Shelkovnikova; S O Bachurin
Journal:  Dokl Biol Sci       Date:  2012-01-07

Review 6.  Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Authors:  Fernanda Martins Lopes; Ivi Juliana Bristot; Leonardo Lisbôa da Motta; Richard B Parsons; Fabio Klamt
Journal:  Neuromolecular Med       Date:  2017-07-18       Impact factor: 3.843

7.  Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation.

Authors:  Jinxia Lu; Shengnan Zhang; Xiaojuan Ma; Chunyu Jia; Zhenying Liu; Chengan Huang; Cong Liu; Dan Li
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

8.  Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein.

Authors:  Jonathan W Werner-Allen; Sarah Monti; Jenna F DuMond; Rodney L Levine; Ad Bax
Journal:  Biochemistry       Date:  2018-02-15       Impact factor: 3.162

Review 9.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

10.  DNAJC13 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alex Rajput; Austen J Milnerwood; Brinda Shah; Chelsea Szu-Tu; Joanne Trinh; Irene Yu; Mary Encarnacion; Lise N Munsie; Lucia Tapia; Emil K Gustavsson; Patrick Chou; Igor Tatarnikov; Daniel M Evans; Frederick T Pishotta; Mattia Volta; Dayne Beccano-Kelly; Christina Thompson; Michelle K Lin; Holly E Sherman; Heather J Han; Bruce L Guenther; Wyeth W Wasserman; Virginie Bernard; Colin J Ross; Silke Appel-Cresswell; A Jon Stoessl; Christopher A Robinson; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Jan O Aasly; Ruey-Meei Wu; Faycal Hentati; Rachel A Gibson; Peter S McPherson; Martine Girard; Michele Rajput; Ali H Rajput; Matthew J Farrer
Journal:  Hum Mol Genet       Date:  2013-11-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.